Talk about a heavy lift. A 22-year-old Brazilian woman has a new lease on life after surgeons removed 22 pounds of excess ...

Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.

For years, she thought it was just part of growing up. But what started as typical development turned into something alarming - and, eventually, debilitating. A 24-year-old woman ...

“Laser facial resurfacing stimulates collagen production in the skin, which helps minimize fine lines and other effects of ...

Thousands of women who undergo radiotherapy for low-risk breast cancer could be spared some of the side effects of treatment after a study confirmed that more targeted treatments are just as effective ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

Prolonged daily sitting is linked to a higher prevalence of breast cancer in obese women, but only among those who are ...

Women who developed a cardiovascular disease or type 2 diabetes were at a higher risk of developing breast cancer post ...

Bebe Buell turns 72 today, and the rock & roll grand dame has never been more vital. Or more appreciative of her time on this planet. Last summer, the singer, songwriter, and model was diagnosed with ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Dr. Anna Pavlov joins us with information about breast reduction surgery options.